Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy
Circulation: Genomic and Precision Medicine · 2024
DOI: 10.1161/circgen.123.004369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2024. Verfasst von Edgar E Nollet und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology (E.E.N., M.S., D.W.D.K., J.v.d.V.), Amsterdam UMC, the Netherlands. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Genotype, Phenotype. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is caused by sarcomere gene mutations (genotype-positive HCM) in ≈50% of patients and occurs in the absence of mutations (genotype-negative HCM) in the other half of patients. We explored how alterations in the metabolomic and lipidomic landscape are involved in cardiac remodeling in both patient groups. METHODS: We performed proteomics, metabolomics, and lipidomics on myectomy samples (genotype-positive N=19; genotype-negative N=22; and genotype unknown N=6) from clinically well-phenotyped patients with HCM and on cardiac tissue samples from sex- and age-matched and body mass index–matched nonfailing donors (N=20). These data sets were integrated to comprehensively map changes in lipid-handling and energy metabolism pathways. By linking metabolomic and lipidomic data to variability in clinical data, we explored patient group–specific associations between cardiac and metabolic remodeling. RESULTS: HCM myectomy samples exhibited (1) increased glucose and glycogen metabolism, (2) downregulation of fatty acid oxidation, and (3) reduced ceramide formation and lipid storage. In genotype-negative patients, septal hypertrophy and diastolic dysfunction correlated with lowering of acylcarnitines, redox metabolites, amino acids, pentose phosphate pathway intermediates, purines, and pyrimidines. In contrast, redox metabolites, amino acids, pentose phosphate pathway intermediates, purines, and pyrimidines were positively associated with septal hypertrophy and diastolic impairment in genotype-positive patients. CONCLUSIONS: We provide novel insights into both general and genotype-specific metabolic changes in HCM. Distinct metabolic alterations underlie cardiac disease progression in genotype-negative and genotype-positive patients with HCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology (E.E.N., M.S., D.W.D.K., J.v.d.V.), Amsterdam UMC, the Netherlands.
- Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, the Netherlands (E.E.N., M.S., D.W.D.K., J.v.d.V.).
- Department of Translational Science Universitätsklinikum, Deutsches Zentrum für Herzinsuffizienz, Würzburg, Germany (V.S.).
- Advanced Clinical Biosystems Research Institute (A.B., J.E.V.E.), Cedars-Sinai Medical Center, Los Angeles, CA.
- Department of Medical Oncology, VUmc Cancer Center Amsterdam, OncoProteomics Laboratory (T.V.P., C.R.J.), Amsterdam UMC, the Netherlands.
- Department of Cardiology, Erasmus MC, Rotterdam, the Netherlands (S.A.C.S., M.M.).
ORCID-Profile: Edgar E Nollet, Maike Schuldt, Vasco Sequeira, Aleksandra Binek, Thang V Pham, Stephan A C Schoonvelde, Mark Jansen, Bauke V Schomakers, Michel van Weeghel, Fred M Vaz, Riekelt H Houtkooper, Jennifer E Van Eyk, Connie R Jimenez, Michelle Michels, Kenneth C Bedi, Kenneth B Margulies, Cristobal G Dos Remedios, Diederik W D Kuster, Jolanda van der Velden
Zitieren
APA
Nollet, E. E., Schuldt, M., Sequeira, V., Binek, A., Pham, T. V., Schoonvelde, S. A. C., Jansen, M., Schomakers, B. V., van Weeghel, M., Vaz, F. M., Houtkooper, R. H., Van Eyk, J. E., Jimenez, C. R., Michels, M., Bedi, K. C., Margulies, K. B., Dos Remedios, C. G., Kuster, D. W. D., & van der Velden, J. (2024). Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.123.004369
Vancouver
Nollet EE, Schuldt M, Sequeira V, Binek A, Pham TV, Schoonvelde SAC, et al. Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy. Circulation: Genomic and Precision Medicine. 2024. doi:10.1161/circgen.123.004369
BibTeX
@article{Nollet2024,
author = {Nollet, Edgar E and Schuldt, Maike and Sequeira, Vasco and Binek, Aleksandra and Pham, Thang V and Schoonvelde, Stephan A C and Jansen, Mark and Schomakers, Bauke V and van Weeghel, Michel and Vaz, Fred M and Houtkooper, Riekelt H and Van Eyk, Jennifer E and Jimenez, Connie R and Michels, Michelle and Bedi, Kenneth C and Margulies, Kenneth B and Dos Remedios, Cristobal G and Kuster, Diederik W D and van der Velden, Jolanda},
title = {Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy},
journal = {Circulation: Genomic and Precision Medicine},
year = {2024},
doi = {10.1161/circgen.123.004369}
}
EUVIMED